An Open-label, Sequential Study to Evaluate the Pharmacokinetics of Digoxin When Coadministered With Albiglutide in Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 14 Jun 2017
At a glance
- Drugs Albiglutide (Primary) ; Digoxin
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 10 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Aug 2010 Actual initiation date added to 1 Jul 2010 as reported by ClinicalTrials.gov.
- 13 Aug 2010 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.